SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 62 filers reported holding SATSUMA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $22,268,000 | +44.9% | 3,711,286 | 0.0% | 3.58% | +10.2% |
| Q2 2022 | $15,365,000 | +8.9% | 3,711,286 | 0.0% | 3.25% | +3.1% |
| Q1 2022 | $14,103,000 | -15.6% | 3,711,286 | 0.0% | 3.15% | -18.6% |
| Q4 2021 | $16,701,000 | +14.9% | 3,711,286 | +19.0% | 3.87% | +0.9% |
| Q3 2021 | $14,533,000 | -33.4% | 3,118,761 | +0.7% | 3.83% | -49.6% |
| Q2 2021 | $21,832,000 | +51.9% | 3,096,729 | +27.3% | 7.61% | +32.9% |
| Q1 2021 | $14,371,000 | – | 2,431,705 | – | 5.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,118,761 | $14,533,000 | 3.83% |
| Ghost Tree Capital, LLC | 904,225 | $4,214,000 | 1.23% |
| RA Capital Management | 5,914,252 | $27,560,000 | 0.38% |
| Vivo Capital, LLC | 1,232,394 | $5,743,000 | 0.26% |
| Nan Fung Group Holdings Ltd | 142,900 | $666,000 | 0.21% |
| Ikarian Capital, LLC | 629,384 | $2,934,000 | 0.21% |
| NEA Management Company, LLC | 3,142,958 | $14,646,000 | 0.17% |
| SAMLYN CAPITAL, LLC | 1,716,067 | $7,998,000 | 0.11% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $8,788,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 90,665 | $422,000 | 0.04% |